We have seen all too many patients have various medicines deprescribed. Often suddenly and without any warning whatsoever.
This has long appeared to be ethically and legally questionable - to say the least. So I have looked for some medicolegal opinions and found this freely accessible paper. Below are the abstract and summary - follow the link for the rest of it.
I fear the context tends rather more towards the case of people on multiple medicines having the prescribing mess sorted - rather than the obvious examples of removing liothyronine or even levothyroxine. But the principles are mostly identical. Mainly:
all decisions must be informed by full and frank informed patient consent
Original article
Deprescribing: is the law on your side?
Free
1. Nina Barnett1,
2. Orla Kelly2
3. Correspondence to Orla Kelly, Healthcare Litigation Solicitor and Pharmacist, Cantillons Solicitors, 38/39 South Mall, Cork, T12 W522, Ireland; orla.kelly@cantillons.com
Abstract
Deprescribing can feel risky: prescribers need to consider the consequence of stopping a medication medicolegally, particularly where there may be a guideline or accepted practice that suggests its use. This review aims to provide reassurance and encouragement to safely deprescribe. Experience suggests that for many patients the prescribing of multiple medicines is the norm. In the right setting and at the right time, deprescribing provides a real opportunity to minimise side effects and unwanted interactions through patient-centred conversations. How does the prescriber stand if they stop a medication for which there is an evidence-based guideline to use it? This review explores the concepts of clinical negligence and informed patient consent in the context of deprescribing. Using examples from UK case law, the review discusses the legal tests which are applied to establish an action based on clinical negligence and lack of informed consent. It describes the recent changes in law which reinforce the importance of providing information focused on what is material to individual patients. The use of prescribing tools to support safe deprescribing and informed consent are also discussed. When deprescribing is undertaken in partnership with patients, supported by the knowledge, skills and experience of both patient and clinicians and the patient's values and preferences based on clinical skill, judgement and evidence-based medicine, law presents no barriers to deprescribing.
dx.doi.org/10.1136/ejhpharm...
Summary
Legally deprescribing is no different to prescribing (within the UK's legal system). Ongoing review and monitoring of all decisions based on patient and medication-specific factors is required for safe patient care and all decisions must be informed by full and frank informed patient consent. As deprescribing becomes the norm practitioners who fail to consider deprescribing and fail to advise patients of the potential benefits and options may expose themselves to clinical negligence claims. Patient consent to stop, start, change or reduce a medicine must be based on full disclosure of all material risks to that patient. In support of the ‘ordinary sensible patient’ we encourage all prescribers to consider discussing the risks and benefits of continuing a medication and the options for deprescribing at the time of prescribing and throughout the patient journey. In the absence of deprescribing guidance as part of evidence-based guidelines, use of deprescribing tools and models are encouraged to support safe practice and improve clinical outcomes. When deprescribing is undertaken in partnership with patients, supported by the knowledge, skills and experience of both patient and clinicians and the patient's values and preferences based on clinical skill, judgement and evidence-based medicine, the law presents no barriers to deprescribing.
Rayray81